meglutol has been researched along with Deficiency, Glucosephosphatase in 1 studies
Meglutol: An antilipemic agent which lowers cholesterol, triglycerides, serum beta-lipoproteins and phospholipids. It acts by interfering with the enzymatic steps involved in the conversion of acetate to hydroxymethylglutaryl coenzyme A as well as inhibiting the activity of HYDROXYMETHYLGLUTARYL COA REDUCTASES which is the rate limiting enzyme in the biosynthesis of cholesterol.
3-hydroxy-3-methylglutaric acid : A dicarboxylic acid that is glutaric acid in which one of the two hydrogens at position 3 is substituted by a hydroxy group, while the other is substituted by a methyl group. It has been found to accumulate in urine of patients suffering from HMG-CoA lyase (3-hydroxy-3-methylglutaryl-CoA lyase, EC 4.1.3.4) deficiency. It occurs as a plant metabolite in Crotalaria dura.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Law, LK | 1 |
| Tang, NL | 1 |
| Hui, J | 1 |
| Lam, CW | 1 |
| Fok, TF | 1 |
1 other study available for meglutol and Deficiency, Glucosephosphatase
| Article | Year |
|---|---|
3-methyglutaconic aciduria in a Chinese patient with glycogen storage disease Ib.
Topics: Adolescent; Blood Glucose; Cholesterol; Diet; DNA; Gluconeogenesis; Glycogen Storage Disease Type I; | 2003 |